1-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine
C32H46N4O2 — CID 154639333
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine
1-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine (PubChem CID 154639333) has the molecular formula C32H46N4O2 and a molecular weight of 518.75 g/mol. Its IUPAC name is 1-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine.
Molecular Properties
| Compound Name | 1-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine |
|---|---|
| PubChem CID | 154639333 |
| Molecular Formula | C32H46N4O2 |
| Molecular Weight | 518.75 g/mol |
| Exact Mass | 518.36 |
| IUPAC Name | 1-[2-(3,4-dimethoxyphenyl)-3-propan-2-yl-1H-indol-5-yl]-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine |
| SMILES | COc1ccc(-c2[nH]c3ccc(N4CCC(NC5CCN(C(C)C)CC5)CC4)cc3c2C(C)C)cc1OC |
| InChI | InChI=1S/C32H46N4O2/c1-21(2)31-27-20-26(8-9-28(27)34-32(31)23-7-10-29(37-5)30(19-23)38-6)36-17-13-25(14-18-36)33-24-11-15-35(16-12-24)22(3)4/h7-10,19-22,24-25,33-34H,11-18H2,1-6H3 |
| InChIKey | IVAJRYGUNZIMEY-UHFFFAOYSA-N |
| XLogP | 6.41 |
| TPSA | 52.76 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 518.75 |
| LogP ≤ 5 | 6.41 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154639333 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.